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Abstract
Background and Objectives: Central neuraxial blocks are the preferred technique for anesthesia for lower segment caesarean
section. Local anesthesia drugs have been routinely used for spinal anesthesia to compare various block characteristics and
hemodynamic changes in patients undergoing lower segment caesarean section using hyperbaric bupivacaine and isobaric levo-
bupivacaine.
Methods: After Institutional ethical committee approval, 100 patients scheduled for elective lower segment caesarean section were
randomized into Group L and Group B. Group L (N = 50) received 2.5 mL (12.5 mg) 0.5% isobaric levo-bupivacaine and Group B (N = 50)
received 2.5 mL (12.5 mg) 0.5% hyperbaric bupivacaine as intra-thecal drugs for spinal anesthesia. The present study was conducted
in Operation theaters and the Post-operative ward of LLRM medical college, Meerut. Difference in characteristics of onset of block,
regression of block, hemodynamic profile, and side effects were recorded between groups.
Results: Group L, in comparison to Group B, showed prolonged duration of sensory block (P = 0.01) with lesser duration of motor
block (P = 0.0002). Hemodynamically hypotension was statistically significant in the bupivacaine group (P = 0.016).
Conclusions: The current study validates that both isobaric levo-bupivacaine and hyperbaric bupivacaine in spinal anesthesia pro-
vide effective surgical anesthesia for lower segment caesarean section. Levo-bupivacaine can be a better alternative to bupivacaine in
terms of reduced motor block time and a longer sensory block time with lesser incidence of hypotension and better hemodynamic
stability.
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1. Background
Neuraxial anesthesia is one of the most common anes-
thesia techniques used for lower segment cesarean section
performed these days. Reducing the risk of airway manipu-
lation and negating the placental transfer of general anes-
thesia drugs to the fetus, neuraxial anesthesia continues to
be the preferred choice of anesthesia. Of all available tech-
niques of neuraxial block, spinal anesthesia is the most
simple to perform with early onset and predictable block
height. The effect of the block depends on the volume,
concentration, and dose of the drug used (1, 2). The ratio
of the density of local anesthetics (LAs) and cerebrospinal
fluid (CSF), which is known as LA baricity, is one key deter-
minant of LA distribution within the subarachnoid space
(3). Bradycardia and hypotension may occur following
mobilization when hyperbaric solutions are used and iso-
baric solutions are favored due to less sensitivity to posi-
tion change properties (4).
Levo-bupivacaine use in clinical practice is due to its re-
duced toxic effects on the heart and central nervous system
(5), as compared to bupivacaine.
Studies comparing levo-bupivacaine and bupivacaine
have been done in lower abdominal surgeries (6), however,
there are few studies in pregnant patients for caesarean
section.
Therefore we did a randomized, double blinded, com-
parative prospective study to compare isobaric Levobupi-
vacaine and hyperbaric Bupivacaine for surgical anaesthe-
sia and post-operative analgesia in patients undergoing
elective lower segment caesarean section.
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2. Methods
After approval from the Institutional Ethical Commit-
tee, the present study was done in operation theaters and
the post-operative ward of Lala Lajpat Rai Memorial Medi-
cal College, Meerut, India. A total of 100 women in the age
group of 18 years to 35 years scheduled for elective lower
segment cesarean section, of more than 35 weeks gesta-
tion, American Society of Anesthesiologists physical status
class I or II, were enrolled in the study.
Patient refusal for regional anesthesia, history of un-
controlled diabetes, hypertension, coagulation abnormal-
ities or any other severe systemic illness like severe res-
piratory, cardiovascular, and neurological disorders, his-
tory of low back surgery, any patient receiving tocolyt-
ics, hormonal preparations, and anti-hypertensive medica-
tions was excluded from the study. Any contraindication to
spinal anesthesia was also considered as the exclusion cri-
teria.
Informed written consent was taken from patients and
the procedure was explained thoroughly to all at the time
of the pre-anesthesia checkup. All necessary routine inves-
tigations were done according to institutional protocol;
body weight, height, and vitals were all recorded. No anxi-
olytics were advised.
Based on a departmental pilot study, considering 95%
confidence interval and 80% power of study sample size of
50 patients in each group was found to be appropriate.
Patients in the study were divided equally and ran-
domly using a computer generated random table into 2
groups:
• Group L - 0.5% Isobaric Levo-bupivacaine group of 50 pa-
tients.
• Group B - 0.5% Hyperbaric Bupivacaine group of 50 pa-
tients.
On the surgical day, the patients were nursed into op-
eration theaters in the left lateral position and the proce-
dure was explained to the patient once again. Once com-
fortable with the surroundings, on the operation table,
multipara monitor (Drager, Infinity Vista XL) was attached
and reading of all vitals, including pulse-rate (HR), systolic
blood pressure (SBP), diastolic blood pressure (DBP), mean
arterial pressures (MAP), and peripheral oxygen saturation
(SPO2) were recorded and marked as baseline values. A to-
tal of 20 G of intra-venous (I.V) cannulation on the dor-
sal aspect of non-dominant forearm was done observing
all sterile precautions and preloading started with ringer
lactate at 10 mL/kg body weight over 10 minutes. After
preloading, the patient was made to sit on the OT table
with an adequate footrest. The assistant was asked to main-
tain the patient in a position such that both the iliac crest
are at same horizontal level and both the shoulders are
at the same horizontal level. The intervertebral space was
identified and under strict aseptic precautions, lumbar
puncture was performed in the midline using 26 G quincke
spinal needle at L2-L3 or L3-L4 space. A total of 2.5 mL of
the drug was injected at 0.2 mL/seconds without barbo-
tage, once free flow of CSF was obtained. Group L patients
received Inj Levobupivacaine [Levo-anawin, Neon pharma-
ceuticals Ltd] 0.5% isobaric 2.5 cc (12.5 mg) intrathecally.
Group B patients received Inj Bupivacaine [Anawin heavy,
Neon pharmaceuticals Ltd] 0.5% hyperbaric 2.5 cc (12.5 mg)
intrathecally. All the patients were comfortable with the
above technique and no discomfort was noted from pa-
tients.
The study medication was prepared and administered
by an anesthesiologist not involved in the present study.
Another anesthetist blind to the identity of study medica-
tion monitored and managed the patients as well as col-
lected data.
After successful completion of subarachnoid drug
placement, patients were made supine. Prior to the start of
the surgery, the anesthesiologist checked the sensory and
motor block level. The level of sensory block was assessed
using the pinprick test using a 25 G blunt needle in the mid
clavicular line. The level of motor block was assessed using
the modified Bromage scale (0 = no motor block, able to
flex hips, knees and ankles; 1 = just able to flex knees, un-
able to extend legs; 2 = able to move ankles, unable to flex
knees; 3 = unable to flex ankles, knees or hips, complete
motor block). Oxygen at 4 L/min was administered using a
face-mask.
No premedication and sedatives were administered
during the course of the surgery.
The characteristics of block were noted at every 2 min-
utes intervals up to 10 minutes, at 15 minutes then every
15 minutes until 90 minutes. After 90 minutes, the above
parameters were noted every 30 minutes up to 240 min-
utes. The time of intra-thecal drug placement was consid-
ered as 0, and then various block characteristics in terms
of time to onset of sensory block until T6, the time to onset
of motor block, the time taken to reach maximum sensory
block level, the time taken to reach maximum motor block,
the time to regression of two dermatomes of the sensory
block, the duration of the regression of the sensory block
level to T12 from the maximum level, and the duration of
return of full motor power was recorded.
Time to complete the motor block was recorded when
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modified Bromage score of 3 was attained. Complete mo-
tor block recovery was defined when modified Bromage
score of 0 was achieved. The patient’s hemodynamic pa-
rameters were recorded at 2 minutes intervals up to 10
minutes and then at 5 minutes interval until 60 minutes
then at 75 minutes, 90 minutes, and then every 30 minutes
until complete regression of motor and sensory block fea-
tures.
The surgeon was asked to proceed once T4 or T6 level
was achieved. The block was considered a failure if com-
plete sensory and motor block was not achieved even after
15 minutes. Failed blocks were converted to GA and were
excluded from study.
Hypotension, defined as a systolic blood pressure less
than 100 mmHg or a decrease of more than 25% from
baseline, was treated with incremental doses of Injection
Mephentermine 6 mg IV. Bradycardia, defined as a heart
rate < 50 beats per minute, was treated with Injection at-
ropine 0.5 mg IV.
2.1. Statistical Analysis
The statistical analysis was done using SPSS (Statistical
Package for Social Sciences) Version 15.0 statistical Analysis
Software. The Qualitative data are represented in Number
(%) and mean± SD. Quantitative data, presented as the pro-
portion or number, were evaluated by χ2 test. P value of <
0.05 was accepted as statistically significant.
3. Results
Table 1 shows the anthropometric variables and
hemoglobin values between Group L and Group B. Both
the groups were similar in terms of anthropometric vari-
ables and were clinically and statistically insignificant (P >
0.05).
Table 2 shows the various block characteristics in terms
of sensory and motor variables.
A total of 62% of patients in the Levobupivacaine group
reached highest dermatome above T4 level as compared to
only 18% in bupivacaine group.
Tables 3 and 4 show the intergroup comparison of
heart rate and mean arterial pressure, respectively.
Table 5 shows the comparison of side effects between
two groups.
4. Discussion
In the current study we compared the effect of isobaric
levo-bupivacaine and hyperbaric bupivacaine in spinal










































































































































































































Figure 2. Comparison of MAP between the groups.
patients in northern India without any adjuvant. Block
characteristics, hemodynamic parameters, and side effects
were compared amongst the groups.
In our study, both the groups were comparable in
terms of anthropometric and demographic variables like
age, weight, height, BMI, and hemoglobin values, and were
statistically insignificant.
In our study, sensory block level required for caesarean
section was achieved adequately in both groups. The time
to reach T6 sensory height, motor onset time, time to reach
maximal sensory blockade, and time to reach full motor
blockade were similar in both the groups and were not sta-
tistically significant (P > 0.05). Vanna et al. reported the
similar block characteristics in a RCT done for endoscopic
uretheral surgery (6).
The 2-segment regression time in minutes was signif-
icantly less for the Levobupivacaine group (81.3 ± 18.45)
as compared to Bupivacaine group (93 ± 24.05) with P =
0.007.
The total duration of sensory blockade was 188.4±22.71
in the Bupivacaine group and 199.8 ± 20.65 Levobupiva-
caine group. The difference is statistically significant (P =
0.01).
The total duration of motor blockade was 201.6 ± 20.14 in
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Table 1. Demographic Profilea , b
Group B (N = 50) Group L (N = 50) t Value P Value
Age (years) 25.78 ± 3.80 25.56 ± 2.84 0.33 0.74
Weight (kg) 52.66 ± 9.49 53.02 ± 9.48 -0.19 0.85
Height (cm) 153.5 ± 5.17 152.84 ± 5.09 0.64 0.52
BMI (kg/m2) 22.38 ± 3.99 22.59 ± 3.09 -0.29 0.77
Hemoglobin (gm %) 9.49 ± 1.39 9.58 ± 1.155 -0.35 0.725
aData are presented as mean ± SD.
bP > 0.05 = No significant difference.
Table 2. Various Block Characteristics in Terms of Sensory and Motor Variablesa , b
Minutes Group B (N = 50) Group L (N =5 0) t Value P Value
Time to reach T6 sensory height 4.28 ± 1.93 4.04 ± 1.78 0.64 0.52
Motor onset time 2.44 ± 0.93 2.4 ± 1.07 0.2 0.84
Time to reach maximal sensory blockade 6.7 ± 2.37 6.92 ± 1.57 -0.54 0.58
Time to reach full motor blockade 6.88 ± 1.90 7.72 ± 3.8 -1.39 0.17
2 segment regression time 93 ± 24.05 81.3 ± 18.45 2.73c 0.007c
Total duration of sensory blockade 188.4 ± 22.71 199.8 ± 20.65 -2.63c 0.01c
Total duration of motor blockade 201.6 ± 20.14 182.4 ± 29.59 3.79c 0.0002c
Highest Dermatome reached T2 - T3 - T4 - T5 - T6 (No. of Patients) 1-8-23-7-11 14-17-11-3-5
Highest Dermatome reached above T4 No. of patient (%) 9 (18%) 31 (62%)
aData are presented as mean ± SD.
bP > 0.05 = No significant difference.
cSignificant difference.
Table 3. Distribution of Mean Heart Rate Between Two Study Groups
Heart Rate Group B (Mean ± SD) Group L (Mean ± SD) t Value P Value
Base line 95.44 ± 14.47 98.36 ± 14.45 -1.01 0.31
2 minutes 94.2 ± 14.49 96.64 ± 14.73 -0.83 0.40
4 minutes 96 ± 20.47 92.86 ± 15.78 0.86 0.39
6 minutes 88.96 ± 15.89 90.7 ± 14.58 -0.57 0.57
8 minutes 89.8 ± 16.26 88.88 ± 15.03 0.29 0.77
10 minutes 92.2 ± 16.02 88.58 ± 14.54 1.18 0.24
15 minutes 94.06 ± 15.61 91.62 ± 14.07 0.82 0.41
20 minutes 95.36 ± 15.86 94.2 ± 12.63 0.40 0.68
25 minutes 94.5 ± 14.86 94.84 ± 11.79 -0.13 0.9
30 minutes 96.42 ± 14.38 95.72 ± 10.70 0.28 0.78
35 minutes 96.74 ± 15.3 95.18 ± 9.29 0.62 0.54
40 minutes 96.56 ± 13.92 93.14 ± 9.94 1.41 0.16
45 minutes 95.68 ± 13.66 93.44 ± 10.67 0.91 0.36
60 minutes 93.38 ± 16.02 88.78 ± 11.34 1.66 0.10
75 minutes 90.74 ± 16.07 86.18 ± 10.12 1.69 0.09
90 minutes 88.34 ± 11.63 85.2 ± 9.65 1.47 0.14
120 minutes 86.88 ± 12.25 83.4 ± 8.99 1.62 0.11
150 minutes 86.3 ± 10.40 82.98 ± 7.49 1.83 0.07
the Bupivacaine group and 182.4 ± 29.59 in the Levobupi-
vacaine group. The difference is statistically significant (P
= 0.0002). Gautier et al. (7) and Gulen Guler et al. (8), dur-
ing spinal anaesthesia for caesarean delivery, also reported
that duration of motor block was shorter in the Levobupi-
vacaine group than in the Bupivacaine group similar to
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Table 4. Distribution of Mean MAP (Mean Arterial Pressures) Between Two Study Groups
M.A.P. Group B (Mean ± SD) Group L (Mean ± SD) t Value P Value
Base line 96.2 ± 8.68 94.64 ± 8.08 0.93 0.35
2 minutes 85.7 ± 12.69 84.08 ± 9.32 0.73 0.47
4minutes 77.84 ± 10.88 79.9 ± 10.32 -0.97 0.33
6 minutes 83.5 ± 10.99 80.3 ± 10.05 1.52 0.13
8 minutes 82.7 ± 9.58 82.44 ± 11.59 0.12 0.90
10 minutes 79.42 ± 8.32 84.08 ± 9.48 -2.61a 0.01a
15 minutes 78.46 ± 10.62 83.14 ± 9.66 -2.30a 0.02a
20 minutes 78.34 ± 9.59 81.38 ± 9.60 -1.58 0.12
25 minutes 77.68 ± 9.35 80.78 ± 10.63 -1.55 0.12
30 minutes 78.3 ± 10.65 80.56 ± 9.77 -1.10 0.27
35 minutes 77.8 ± 10.91 80.28 ± 10.21 -1.17 0.24
40 minutes 80.98 ± 12.09 81.92 ± 9.38 -0.43 0.66
45 minutes 81.04 ± 9.85 81.6 ± 14.35 -0.23 0.82
60 minutes 84.5 ± 8.10 85.98 ± 8.03 -0.92 0.36
75 minutes 86.12 ± 8.12 88.64 ± 8.21 -1.54 0.12
90 minutes 87.9 ± 6.22 89.12 ± 6.47 -0.96 0.34
120 minutes 90.32 ± 7.02 89.58 ± 5.75 0.58 0.56
150 minutes 90.32 ± 6.27 90.6 ± 5.78 -0.23 0.82
aSignificant difference in MAP.
Table 5. Comparison of Side Effects Between Two Groups




χ2 Value P Value
Bradycardia 3 1 1.04 0.31
Hypotension 31 20 5.77a 0.016a
Nausea 5 1 2.83 0.09
Vomiting 2 1 0.34 0.56
aSignificant difference.
findings in our study. Lower affinity of Levobupivacaine to
A-α fibers (somatic motor fibers) than that of Bupivacaine
may have resulted in a lesser motor block.
Patients in the Levobupivacaine group achieved sta-
tistically higher block height than patients in the Bupiva-
caine group, which may be due to its isobaric nature. This
finding was similar to the study of Vanna et al. (6) and Dilek
Subasi et al. (9).
Incidence of hypotension as side effects was seen more
in the bupivacaine group as compared to the levobupiva-
caine group and was clinically significant P = 0.016. Other
side effects like bradycardia, nausea, and vomiting were
also more in the Bupivacaine group than the Levobupiva-
caine, however, this was statistically insignificant P > 0.05.
It has been shown that the sympathetic nervous system - re-
lated side effects of levobupivacaine are less frequent than
those associated with the use of bupivacaine and the mean
convulsive dose for levobupivacaine is higher than that of
bupivacaine (10).
Hemodynamic parameters such as heart rate and
Mean arterial pressure were similar in both groups and
statistically insignificant except at 10 and 15 minutes after
spinal, when mean arterial pressure showed a significant
difference between the two groups (P < 0.05). Good hemo-
dynamic stability, with a reduced prevalence of side effects,
has been shown for intrathecal levobupivacaine in elderly
patients also in studies by Cuvas et al. and Erdil et al. (11, 12).
4.1. Conclusion
In conclusion, this study shows that spinal anaesthe-
sia performed with both local anaesthetic drugs provides
fast and effective induction of surgical anaesthesia for cae-
sarean section. Since motor block time is shorter, sensory
block time longer, better hemodynamic stability and lesser
patients with hypotension, the Levobupivacaine can be a
better alternative in caesarean sections.
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